Stockreport

Centessa Pharmaceuticals Teases ORX750 Phase II Update, Registrational Study Start at Conference [Yahoo! Finance]

Centessa Pharmaceuticals plc - American Depositary Shares  (CNTA) 
PDF and aims to start registrational studies for rare hypersomnias (NT2 and idiopathic hypersomnia) this quarter while outlining registrational design and regulatory strateg [Read more]